Bionoid Pharma (OTC Pink: BINP), a Toronto, Canada-based bio-research company, announced is to acquire AiMaverickIntel.com, a Dallas, Texas-based provider of an audience acquisition platform empowered by artificial intelligence (AI).
The amount of the deal was not disclosed. The transaction is expected to close in within 45 days, pending customary closing conditions and regulatory approvals.
By integrating AiMaverickIntel.com’s capabilities, BINP aims to achieve substantial improvements in customer engagement and acquisition metrics.
AiMaverickIntel.com offers a platform that helps companies identify, reach, and engage their target audience segments. Its advanced algorithms and machine learning capabilities provide actionable insights and optimize customer acquisition processes.
According to a press release, this new agreement follows the cancellation of a previously announced agreement to acquire Global Alerts Corp. As detailed in a prior release, Bionoid Pharma signed a binding letter of intent to acquire Global Alerts Corp., however strategic considerations led the company to pursue the acquisition of AiMaverickIntel.com instead.
FinSMEs
20/06/2024